Hours after disclosing late-day news June 30 that his company's Feraheme at last won approval from the FDA, an exhilarated Brian J.G. Pereira, president and CEO of AMAG Pharmaceuticals Inc., told BioWorld Insight the iron-replacement would be priced "at a premium" to others on the market. Read More
